Skip to Main Content

Paper Details

Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume.
J Opioid Manag
6
2017
Author NameAffiliation
Paul M CoplanPurdue Pharma L.P.
  • 1 - 1

Datasets

Release 1.2